Skip to main content
logo
Guardant Health, Inc. (FRA:5GH)
Germany flag Germany · Delayed Price · Currency is EUR
82.50
+0.04 (0.05%)
At close: Dec 19, 2025

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
United States Revenue
851.33M697.16M
Log In
Log In
Log In
Upgrade
International Revenue
51.24M41.85M
Log In
Log In
Log In
Upgrade
Revenue (Total)
902.57M739.02M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Precision Oncology Testing Revenue
-687.94M
Log In
Log In
Log In
Upgrade
Development Services and Other Revenue
-51.08M
Log In
Log In
Log In
Upgrade
Revenue (Total)
902.57M739.02M
Log In
Log In
Log In
Upgrade

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Precision Oncology Testing Gross Profit
-427.36M
Log In
Log In
Log In
Upgrade
Development Services and Other Gross Profit
-21.86M
Log In
Log In
Log In
Upgrade
Gross Profit (Total)
902.57M449.22M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212014 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2014 - 2020
Clinical Test Sales Volume
254.30K206.70K
Log In
Log In
Log In
Upgrade
Biopharmaceutical Test Sales Volume
-40.50K
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.